New York- Pfizer Inc. has extended an invitation to investors and the public to engage in a webcast of a conference call scheduled for 10 a.m. EST on Tuesday, January 30, 2024. The conference call aims to present an overview of Pfizer’s performance, focusing on the Fourth Quarter and Full Year 2023 Performance Report.

For those interested in participating in the webcast and reviewing the Performance Report, the company directs individuals to visit their official website. Comprehensive information regarding webcast access and registration can be found at www.pfizer.com/investors, with registration recommended in advance of the scheduled conference call.

Alternatively, participants can join the conference call by dialing 800-456-4352 within the United States and Canada, or 785-424-1086 outside of these regions. The passcode for accessing the call is “84692”.

Also Read: A Conversation with Patrick Van Der Loo on Pfizer and AIWF’s ‘DEI by Design’ Report

Pfizer’s official website will promptly make available a transcript and webcast replay following the live conference call. Interested parties can access these resources within 24 hours after the call’s conclusion, and the materials will remain accessible for at least 90 days.

Readers Also Read: Pfizer and AIWF released ‘DEI by Design’ report on diversity in MENA healthcare